Companies — profitable or not — make 2024 the year of cost cuts
Mathisworks | Digitalvision Vectors | Getty ImagesCorporate America has a message for Wall Street: It's serious about cutting costs this ...
Tag: Goldman Sachs Group Inc
How Walmart, Delta, Chevron and Starbucks are using AI to monitor employee messages
Klaus Vedfelt | Digitalvision | Getty ImagesCue the George Orwell reference.Depending on where you work, there's a significant chance that ...
A Goldman Sachs-backed electricity firm is making a play to reach more Americans’ homes
Omar Marques | Lightrocket | Getty Images Goldman Sachs abandoned an ill-fated push into consumer banking in late 2022, but ...
New Morgan Stanley CEO is ‘super bullish’ on hitting financial targets
Morgan Stanley's new CEO Ted Pick on Thursday expressed confidence that his bank will hit financial targets of $10 trillion ...
Jamie Dimon warns ‘all these very powerful forces’ will impact U.S. economy in 2024 and 2025
JPMorgan Chase CEO Jamie Dimon said he remains cautious on the U.S. economy over the next two years because of ...
Goldman Sachs is set to report fourth-quarter earnings — here’s what the Street expects
David Solomon, Chairman and CEO, Goldman Sachs, participates in a panel discussion during the annual Milken Institute Global Conference at ...
Citigroup posts $1.8 billion fourth-quarter loss after litany of charges
Citigroup on Friday posted a $1.8 billion fourth-quarter loss after booking several large charges tied to overseas risks, last year's ...
JPMorgan Chase is set to report fourth-quarter earnings. Here’s what the Street expects
Jamie Dimon, CEO of JPMorgan Chase, testifies during the Senate Banking, Housing and Urban Affairs Committee hearing titled Annual Oversight ...
Citigroup at risk of quarterly loss after charges come in far higher than initially disclosed
Jane Fraser CEO, Citi, speaks at the 2023 Milken Institute Global Conference in Beverly Hills, California, May 1, 2023.Mike Blake ...
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or ...
